(Q40341471)

19 September 2017

Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. (English)

1 reference

19 September 2017

0 references

1 reference

1 reference

1 reference

Boyu Du

1

1 reference

19 September 2017

Liping Jiang

series ordinal

2

1 reference

19 September 2017

Quan Xia

series ordinal

3

1 reference

19 September 2017

Laifu Zhong

series ordinal

4

1 reference

19 September 2017

language of work or name

1 reference

9 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

52

1 reference

19 September 2017

23-28

1 reference

19 September 2017

1

1 reference

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

19 September 2017

1 reference

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats

21 January 2018

1 reference

A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regim

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090238

1 reference

19 September 2017

1 reference